Out of six professionals IBJ profiled a year ago, three have found jobs, although all have accepted lower pay than
they were getting before. One could not be reached, but she still lists herself as looking for work on LinkedIn.com. Two tried
to start their own businesses, with one giving up and one, Bruce Flanagan, still trying.
Gov. Mitch Daniels should step through the door he cracked open last month and throw
his hat in the ring. Voters would benefit from a new voice.
Agricultural biotech firm hired a site-selection consultant and considered other cities around the world for its $340 million
expansion.
The investment will greatly expand the company’s research and development capacity and is a major win for the Indiana
life sciences industry. Dow AgroSciences expects most of the positions to pay between $65,000 and $95,000 annually.
Dr. Gregory N. Larkin, the former global medical director at Eli Lilly and Co., will replace Dr. Judy Monroe, who is leaving
to become deputy director of the Centers for Disease Control and Prevention.
The former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
Drug developer Transition Therapeutics Inc. said Wednesday that it will pay $1 million to license a group of potential diabetes
drugs from Eli Lilly and Co.
Dr. Judy Monroe will end a five-year run as Indiana state commissioner of health on March 8. She will become
deputy director of the U.S. Centers for Disease Control and Prevention, overseeing communication between federal and state
public health agencies. Until Gov. Mitch Daniels names a replacement, Monroe’s deputy, Loren Robertson, will fill her
shoes.
Community Heart and Vascular, a unit of Community Health Network, named Kevin Fowler chief financial officer.
Fowler, who earned his MBA at Indiana State University, has been the CFO at Lubbock Heart Hospital in Texas since 2007.
Community Heart and Vascular hired two electrophysiologists, Dr. Chad Bonhomme and Dr. Krishna Malineni,
along with Dr. Shalabh Singhal, an invasive cardiologist. The unit of Community Health Network has now hired
eight physicians in the past year.
OrthoWorx, a Warsaw-based group focused on advancing the city’s orthopedics implant industry, named Cheryl
Blanchard as its chairperson. Blanchard is chief scientific officer at Warsaw-based Zimmer Holdings Inc.
Bloomington-based Cook Pharmica promoted Veda Walcott to be its vice president of quality and corporate
compliance officer. Walcott has worked for Cook Pharmica since 2005 after stints at Cook Medical and Baxter BioPharma Solutions.
Dr. Richard Aina, an internist who focuses on chronic diseases, has joined St. Vincent Physician Network
in Indianapolis. Aina received his medical degree from the University of Illinois College of Medicine in Champaign, Ill.
Duane M. Schmitz, a former executive at Eli Lilly and Co., has joined Indianapolis-based Harrison College
as president of its online division. Nearly half of the for-profit school’s students take at least one course online.
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper.
Greenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
Granting of foreign trade zone status should help the Indianapolis-based mobile device distributor be more competitive in
the global wireless market, company executive says.
Rolls-Royce Corp.’s Indianapolis manufacturing facility has been awarded a multimillion-dollar contract by the U.S. Army to
develop a digital engine control for one of its helicopters.
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
The not-for-profit on Monument Circle announced its initiation fees will be waived for all chamber members.
Arkansas Attorney General Dustin McDaniel on Tuesday announced an $18.5 million settlement of a lawsuit with Eli Lilly &
Co. over off-label marketing of the anti-psychotic drug Zyprexa.
